**Core Concept**
Gastric acid secretion is regulated by a complex interplay of neurotransmitters, hormones, and local mediators, involving cholinergic, histaminergic, and gastrinergic pathways. The drugs used to inhibit gastric acid secretion can target these pathways at various levels.

**Why the Correct Answer is Right**
Omeprazole is a proton pump inhibitor (PPI) that selectively blocks the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells. This action inhibits the final step of acid production, namely the transport of hydrogen ions into the gastric lumen, without affecting cholinergic (acetylcholine), histaminergic (histamine), or gastrinergic (gastrin) receptors. Omeprazole's mechanism of action is independent of the receptor-mediated pathways involved in gastric acid secretion, making it a potent inhibitor of both basal and stimulated acid secretion.

**Why Each Wrong Option is Incorrect**
**Option A:** Sucralfate works by forming an ulcer-adherent complex that protects the ulcer crater from acid, but it does not affect gastric acid secretion directly.
**Option B:** Lansoprazole is another proton pump inhibitor (PPI) that works similarly to omeprazole, but it is not the correct answer because the question asks for a specific drug that blocks basal as well as stimulated gastric acid secretion without affecting cholinergic, histaminergic, or gastrin receptors, and omeprazole is the correct answer due to its unique mechanism of action.
**Option C:** Misoprostol is a synthetic prostaglandin E1 analogue that inhibits gastric acid secretion by stimulating cyclic AMP production, but it affects gastric acid secretion indirectly by inhibiting gastrin release and gastric motility.

**Clinical Pearl / High-Yield Fact**
PPIs like omeprazole are highly effective in treating conditions like gastroesophageal reflux disease (GERD), peptic ulcer disease, and Zollinger-Ellison syndrome, and their use has revolutionized the management of acid-related disorders.

**Correct Answer:** C.